MA31800B1 - Dérivés de tétrahydroquinoléine pour traiter des troubles de stress post-traumatique - Google Patents
Dérivés de tétrahydroquinoléine pour traiter des troubles de stress post-traumatiqueInfo
- Publication number
- MA31800B1 MA31800B1 MA32806A MA32806A MA31800B1 MA 31800 B1 MA31800 B1 MA 31800B1 MA 32806 A MA32806 A MA 32806A MA 32806 A MA32806 A MA 32806A MA 31800 B1 MA31800 B1 MA 31800B1
- Authority
- MA
- Morocco
- Prior art keywords
- ptsd
- treatment
- tetrahydroquinoline derivatives
- derivatives
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
L'invention concerne l'utilisation de dérivés de tétrahydroquinoléine représentés par la formule (i), r1 et r2 représentant chacun indépendamment un groupe alcoxy en c1-c4, r3 représentant un groupe arylalkyle en c1-c4 ou hétéroarylalkyle en c1-c4, et r4 représentant un atome d'hydrogène ou un groupe alkyle en c1-c4, ou de sels pharmaceutiquement acceptables de ces dérivés, pour la préparation d'un médicament destiné à prévenir ou traiter des troubles de stress post-traumatique.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2007054130 | 2007-10-10 | ||
PCT/IB2008/054138 WO2009047723A2 (fr) | 2007-10-10 | 2008-10-09 | Dérivés de tétrahydroquinoléine pour traiter des troubles de stress post-traumatique |
Publications (1)
Publication Number | Publication Date |
---|---|
MA31800B1 true MA31800B1 (fr) | 2010-10-01 |
Family
ID=40467356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA32806A MA31800B1 (fr) | 2007-10-10 | 2010-04-30 | Dérivés de tétrahydroquinoléine pour traiter des troubles de stress post-traumatique |
Country Status (28)
Country | Link |
---|---|
US (1) | US9532985B2 (fr) |
EP (1) | EP2207550B1 (fr) |
JP (1) | JP5883222B2 (fr) |
KR (1) | KR101733247B1 (fr) |
CN (1) | CN101820878B (fr) |
AR (1) | AR068768A1 (fr) |
AU (1) | AU2008309194B2 (fr) |
BR (1) | BRPI0818617A2 (fr) |
CA (1) | CA2699504C (fr) |
CY (1) | CY1114799T1 (fr) |
DK (1) | DK2207550T3 (fr) |
EA (1) | EA017443B1 (fr) |
ES (1) | ES2444418T3 (fr) |
HK (1) | HK1145440A1 (fr) |
HR (1) | HRP20140214T1 (fr) |
IL (1) | IL204838A (fr) |
MA (1) | MA31800B1 (fr) |
MX (1) | MX2010003711A (fr) |
MY (1) | MY153044A (fr) |
NZ (1) | NZ585086A (fr) |
PE (1) | PE20091010A1 (fr) |
PL (1) | PL2207550T3 (fr) |
PT (1) | PT2207550E (fr) |
SI (1) | SI2207550T1 (fr) |
TW (1) | TWI428129B (fr) |
UA (1) | UA99150C2 (fr) |
WO (1) | WO2009047723A2 (fr) |
ZA (1) | ZA201003251B (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010513466A (ja) | 2006-12-22 | 2010-04-30 | アクテリオン ファーマシューティカルズ リミテッド | 5,6,7,8−テトラヒドロ−イミダゾ[1,5−a]ピラジン誘導体 |
CN102076694A (zh) | 2008-06-25 | 2011-05-25 | 埃科特莱茵药品有限公司 | 5,6,7,8-四氢-咪唑并[1,5-a]吡嗪化合物 |
EP2402322A1 (fr) | 2010-07-02 | 2012-01-04 | Actelion Pharmaceuticals Ltd. | Dérivé de 1,2,3,4-tétrahydroisoquinoline et son utilisation comme antagoniste du récepteur de l'orexine |
JP5744203B2 (ja) | 2010-08-24 | 2015-07-08 | アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd | オレキシン受容体拮抗薬としてのプロリンスルフォンアミド誘導体 |
PT2626350E (pt) | 2010-09-22 | 2015-08-03 | Eisai R&D Man Co Ltd | Composto de ciclopropano |
US9242970B2 (en) | 2010-11-10 | 2016-01-26 | Actelion Pharmaceuticals Ltd. | Lactam derivatives useful as orexin receptor antagonists |
WO2012085852A1 (fr) | 2010-12-22 | 2012-06-28 | Actelion Pharmaceuticals Ltd | 3,8-diaza-bicyclo[4.2.0]oct-8-ylamides |
ES2541531T3 (es) | 2011-02-18 | 2015-07-21 | Actelion Pharmaceuticals Ltd. | Nuevos derivados de pirazol e imidazol útiles como antagonistas de orexina |
WO2012114252A1 (fr) | 2011-02-21 | 2012-08-30 | Actelion Pharmaceuticals Ltd | Nouveaux amides d'indole et de pyrrolopyridine |
WO2013050938A1 (fr) | 2011-10-04 | 2013-04-11 | Actelion Pharmaceuticals Ltd | Dérivés de 3,7-diazabicyclo[3.3.1]nonane et de 9-oxa-3,7- diazabicyclo[3.3.1]nonane |
AR088692A1 (es) | 2011-11-08 | 2014-06-25 | Actelion Pharmaceuticals Ltd | Derivados de 2-(1,2,3-triazol-2-il)benzamina y 3-(1,2,3-triazol-2-il)picolinamida |
DK2855453T3 (en) | 2012-06-04 | 2017-02-06 | Actelion Pharmaceuticals Ltd | Benzimidazol-proline derivatives |
BR112015007516A2 (pt) | 2012-10-10 | 2017-07-04 | Actelion Pharmaceuticals Ltd | antagonistas do receptor de orexina que são derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)- pirrolidin-1-il]-metanona |
EP2970241A1 (fr) | 2013-03-12 | 2016-01-20 | Actelion Pharmaceuticals Ltd. | Dérivés d'amide d'azétidine en tant qu'antagonistes des récepteurs d'oréxine |
UA119151C2 (uk) | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА |
MX364208B (es) | 2013-12-03 | 2019-04-16 | Idorsia Pharmaceuticals Ltd | Forma cristalina de (s)-(2-(6-cloro)-7-metil-1h-benzo[d]imidazol-2 -il)-2-metilpirrolidin-1-il) (5-metoxi-2-(2h-1,2,3-triazol-2-il)fe nil) metanona y su uso como antagonistas de receptor de orexina. |
KR102330133B1 (ko) | 2013-12-04 | 2021-11-23 | 이도르시아 파마슈티컬스 리미티드 | 벤즈이미다졸-프롤린 유도체의 용도 |
CN107810006B (zh) | 2014-10-23 | 2021-03-30 | 卫材R&D管理有限公司 | 用于治疗失眠的组合物 |
CN115710250A (zh) * | 2017-08-01 | 2023-02-24 | 博健制药有限责任公司 | 一种食欲素受体拮抗剂的晶型及其制备方法和用途 |
WO2020007964A1 (fr) | 2018-07-05 | 2020-01-09 | Idorsia Pharmaceuticals Ltd | Dérivés de 2-(2-azabicyclo [3.1.0] hexan-1-yl)-1h-benzimidazole |
WO2020007977A1 (fr) | 2018-07-06 | 2020-01-09 | Idorsia Pharmaceuticals Ltd | Dérivés de 7-trifluorométhyl-[1,4]diazépane |
WO2020099511A1 (fr) | 2018-11-14 | 2020-05-22 | Idorsia Pharmaceuticals Ltd | Dérivés de benzimidazole-2-méthyl-morpholine |
WO2023218023A1 (fr) | 2022-05-13 | 2023-11-16 | Idorsia Pharmaceuticals Ltd | Dérives d'hydrazine-n-carboxamide cycliques substitués par thiazoloaryl-méthyle |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA02008797A (es) | 2000-03-14 | 2005-09-08 | Actelion Pharmaceuticals Ltd | Derivados de 1,2,3,4-tetrahidroisoquinolina. |
CA2518945A1 (fr) * | 2003-03-26 | 2004-10-07 | Actelion Pharmaceuticals Ltd. | Derives de tetrahydro-isoquinolyl-acetamide destines a servir d'antagonistes des recepteurs d'orexine |
CA2557163C (fr) | 2004-03-01 | 2011-08-16 | Actelion Pharmaceuticals Ltd | Derives de 1,2,3,4-tetrahydroisoquinoleine substitues |
US7501395B2 (en) | 2005-04-25 | 2009-03-10 | Eisai R & D Management Co., Ltd. | Method of screening for antianxiety drugs |
BRPI0708913A2 (pt) | 2006-03-15 | 2011-06-14 | Actelion Pharmaceuticals Ltd | uso de compostos derivados de tetraidroisoquinolina para aumentar a funÇço da memària |
EP2402322A1 (fr) | 2010-07-02 | 2012-01-04 | Actelion Pharmaceuticals Ltd. | Dérivé de 1,2,3,4-tétrahydroisoquinoline et son utilisation comme antagoniste du récepteur de l'orexine |
-
2008
- 2008-10-07 PE PE2008001739A patent/PE20091010A1/es not_active Application Discontinuation
- 2008-10-09 PT PT88079371T patent/PT2207550E/pt unknown
- 2008-10-09 AU AU2008309194A patent/AU2008309194B2/en not_active Ceased
- 2008-10-09 US US12/681,802 patent/US9532985B2/en active Active
- 2008-10-09 BR BRPI0818617-0A patent/BRPI0818617A2/pt not_active Application Discontinuation
- 2008-10-09 EA EA201000557A patent/EA017443B1/ru not_active IP Right Cessation
- 2008-10-09 NZ NZ585086A patent/NZ585086A/en unknown
- 2008-10-09 JP JP2010528515A patent/JP5883222B2/ja active Active
- 2008-10-09 ES ES08807937.1T patent/ES2444418T3/es active Active
- 2008-10-09 CN CN2008801113334A patent/CN101820878B/zh active Active
- 2008-10-09 KR KR1020107010186A patent/KR101733247B1/ko active IP Right Grant
- 2008-10-09 WO PCT/IB2008/054138 patent/WO2009047723A2/fr active Application Filing
- 2008-10-09 MY MYPI2010001561A patent/MY153044A/en unknown
- 2008-10-09 CA CA2699504A patent/CA2699504C/fr active Active
- 2008-10-09 SI SI200831152T patent/SI2207550T1/sl unknown
- 2008-10-09 PL PL08807937T patent/PL2207550T3/pl unknown
- 2008-10-09 UA UAA201005122A patent/UA99150C2/ru unknown
- 2008-10-09 TW TW097139093A patent/TWI428129B/zh active
- 2008-10-09 MX MX2010003711A patent/MX2010003711A/es active IP Right Grant
- 2008-10-09 DK DK08807937.1T patent/DK2207550T3/da active
- 2008-10-09 EP EP08807937.1A patent/EP2207550B1/fr active Active
- 2008-10-09 AR ARP080104422A patent/AR068768A1/es unknown
-
2010
- 2010-04-06 IL IL204838A patent/IL204838A/en active IP Right Grant
- 2010-04-30 MA MA32806A patent/MA31800B1/fr unknown
- 2010-05-07 ZA ZA2010/03251A patent/ZA201003251B/en unknown
- 2010-12-17 HK HK10111852.2A patent/HK1145440A1/xx not_active IP Right Cessation
-
2014
- 2014-02-04 CY CY20141100085T patent/CY1114799T1/el unknown
- 2014-03-10 HR HRP20140214AT patent/HRP20140214T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA31800B1 (fr) | Dérivés de tétrahydroquinoléine pour traiter des troubles de stress post-traumatique | |
TNSN07178A1 (fr) | N-sulfonylaminobenzyl-2-phenoxy-acetamides substitues | |
MA28747B1 (fr) | Dérivés de pyridine | |
MA26875A1 (fr) | Composes azapolycycliques a noyau aryle condensé | |
TNSN04137A1 (fr) | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases | |
MA31979B1 (fr) | (cyclopropylphenyl) phenyloxamides, leur procede de production et leur utilisation comme medicament | |
MA30403B1 (fr) | Derives d'acides cycloalkylamines et leurs compositions pharmaceutiques | |
MA33636B1 (fr) | Dérivés aminopropioniques substitués comme inhibiteurs de néprilysine | |
MA27775A1 (fr) | Composes organiques | |
WO2005012269A8 (fr) | Nouveau compose azole | |
MA37929B1 (fr) | Composés bis(fluoroalkyl) -1,4-benzodiazépinones en tant qu'inhibiteurs de notch | |
TNSN05073A1 (fr) | Quinazolinones spirocondensees nouvelles et leur utilisation comme inhibiteurs de phosphodiesterase | |
MA27735A1 (fr) | Heterocycles de n-aryle substitues, procede pour leur preparation et leur utilisation en tant que medicaments | |
MA31710B1 (fr) | (carboxylalkylenephenyl)phényloxamides, procédés pour la production de ceux-ci et utilisation de ceux-ci en tant que medicament | |
SE0104334D0 (sv) | Therapeutic agents | |
HK1077567A1 (en) | Dibenzylamine compound and medicinal use thereof | |
MA31146B1 (fr) | Composes inhibant la phosphoinositide 3 kinase et procedes d'utilisation | |
MA34450B1 (fr) | Dérivés de l'imidazopyridine, procédé pour leur préparation, et leur utilisation thérapeutique | |
WO2002008219A3 (fr) | Nouvelles 2-adamantylethylamines et leur utilisation dans le traitement d'etats generalement associes a des anomalies de la transmission glutamatergique | |
MA29926B1 (fr) | Derives de pyrazine | |
MA30420B1 (fr) | Derives de terphenyle pour le traitment de la maladie d'alzheimer | |
DE60130119D1 (de) | Phenylpyridazinderivate und diese enthaltende arzneimittel | |
MY146599A (en) | New azetidine compounds | |
MA31674B1 (fr) | Dérivés de 7 -alkynyl-1,8-naphthyridones, leur préparation et leur application en thérapeutique | |
NO922223L (no) | ((arylalkylpiperidin-4-yl)metyl)-2a,3,4,5-tetrahydro-1(2h)-acenaftylen-1-oner og beslektede forbindelser, fremgangsmaate for fremstilling og anvendelse som medikamenter |